These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31665029)

  • 1. The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma.
    Zhu H; Miao Y; Shen Y; Guo J; Xie W; Zhao S; Dong W; Zhang Y; Li C
    J Transl Med; 2019 Oct; 17(1):354. PubMed ID: 31665029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline mutations in
    Zhu H; Miao Y; Shen Y; Guo J; Xie W; Zhao S; Dong W; Zhang Y; Li C
    Oncol Lett; 2020 Jul; 20(1):561-568. PubMed ID: 32565981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas.
    Monsalves E; Juraschka K; Tateno T; Agnihotri S; Asa SL; Ezzat S; Zadeh G
    Endocr Relat Cancer; 2014 Aug; 21(4):R331-44. PubMed ID: 25052915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cucurbitacin I blocks cerebrospinal fluid and platelet derived growth factor-BB stimulation of leptomeningeal and meningioma DNA synthesis.
    Johnson MD; O'Connell MJ; Walter K
    BMC Complement Altern Med; 2013 Nov; 13():303. PubMed ID: 24188277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.
    Beauchamp RL; Erdin S; Witt L; Jordan JT; Plotkin SR; Gusella JF; Ramesh V
    J Biol Chem; 2021; 296():100157. PubMed ID: 33273014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.
    Mei Y; Du Z; Hu C; Greenwald NF; Abedalthagafi M; Agar NYR; Dunn GP; Bi WL; Santagata S; Dunn IF
    Cell Commun Signal; 2017 Sep; 15(1):34. PubMed ID: 28923059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nelfinavir induces radiation sensitization in pituitary adenoma cells.
    Zeng J; See AP; Aziz K; Thiyagarajan S; Salih T; Gajula RP; Armour M; Phallen J; Terezakis S; Kleinberg L; Redmond K; Hales RK; Salvatori R; Quinones-Hinojosa A; Tran PT; Lim M
    Cancer Biol Ther; 2011 Oct; 12(7):657-63. PubMed ID: 21811091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lopinavir inhibits meningioma cell proliferation by Akt independent mechanism.
    Johnson MD; O'Connell M; Pilcher W
    J Neurooncol; 2011 Feb; 101(3):441-8. PubMed ID: 20596751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histochemical and immunohistochemical features of a case showing association of meningioma and prolactinoma containing amyloid.
    Canda T; Sengiz S; Canda MS; Acar UD; Erbayraktar RS; Yilmaz HS
    Brain Tumor Pathol; 2002; 19(1):1-3. PubMed ID: 12455881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the MEN1 tumor suppressor gene in sporadic pituitary tumors.
    Wenbin C; Asai A; Teramoto A; Sanno N; Kirino T
    Cancer Lett; 1999 Jul; 142(1):43-7. PubMed ID: 10424779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
    Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
    Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol Induces Apoptosis and Autophagy via the AKT/mTOR Signaling Pathway in the Pituitary ACTH-secreting Adenoma Cells.
    Cai Z; Qian B; Pang J; Tan ZB; Zhao K; Lei T
    Curr Med Sci; 2022 Apr; 42(2):387-396. PubMed ID: 35419676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased menin expression in sporadic pituitary adenomas.
    Wrocklage C; Gold H; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
    Clin Endocrinol (Oxf); 2002 May; 56(5):589-94. PubMed ID: 12030908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR Signaling and Potential Therapeutic Targeting in Meningioma.
    Pinker B; Barciszewska AM
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEN1 and pituitary adenomas.
    Delemer B
    Ann Endocrinol (Paris); 2012 Apr; 73(2):59-61. PubMed ID: 22542456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1 inhibitors suppress meningioma growth in mouse models.
    Pachow D; Andrae N; Kliese N; Angenstein F; Stork O; Wilisch-Neumann A; Kirches E; Mawrin C
    Clin Cancer Res; 2013 Mar; 19(5):1180-9. PubMed ID: 23406776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice.
    Dai C; Zhang B; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wang J; Guo K; Ma W; Xing B; Lian W; Xiao J; Cai F; Zhang H; Wang R
    Endocrinology; 2013 Mar; 154(3):1247-59. PubMed ID: 23384836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lncRNA HULC knockdown on rat secreting pituitary adenoma GH3 cells.
    Rui QH; Ma JB; Liao YF; Dai JH; Cai ZY
    Braz J Med Biol Res; 2019; 52(4):e7728. PubMed ID: 30994730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN1 gene replacement therapy reduces proliferation rates in a mouse model of pituitary adenomas.
    Walls GV; Lemos MC; Javid M; Bazan-Peregrino M; Jeyabalan J; Reed AA; Harding B; Tyler DJ; Stuckey DJ; Piret S; Christie PT; Ansorge O; Clarke K; Seymour L; Thakker RV
    Cancer Res; 2012 Oct; 72(19):5060-8. PubMed ID: 22915754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.